H ypertrophic cardiomyopathy (HCM) is an inherited cardiomyopathy with variable clinical expression ranging from asymptomatic status to progressive heart failure or sudden death. 1-3 Previously, left ventricular outflow tract obstruction (LVOTO) has been demonstrated to be independently associated with adverse HCM-related outcomes. 4, 5 When evaluated carefully, dynamic LVOTO is observed in ≈70% patients with HCM, with a majority of such patients demonstrating severe asymmetrical basal septal hypertrophy and systolic anterior motion (SAM) of the mitral valve (MV). 6 A significant proportion of such patients require invasive therapies (myectomy or alcohol septal ablation) to relieve LVOTO and intractable symptoms. Multiple studies have demonstrated excellent long-term outcomes after these procedures, 7-15 potentially altering the natural history to that of an age-matched population. 7
echocardiography and cardiac magnetic resonance [CMR]), we now frequently encounter patients with HCM who have dynamic LVOTO, without severe basal septal hypertrophy. 16, 17 In such patients, abnormalities in MV and papillary muscles (PM) are suspected to result in dynamic LVOTO [18] [19] [20] [21] (Figures 1-3 ; Movies I-III in the Data Supplement). From a clinical management perspective, it is important to recognize that these patients as isolated myectomy or alcohol septal ablation would not effectively relieve LVOTO. In a recent study, we have demonstrated that around a quarter of patients with HCM required more than an isolated surgical myectomy (ie, concomitant MV repair/replacement) to optimally relieve LVOTO. 15 We also demonstrated that a significantly higher proportion of patients with a basal septal thickness of <2 cm required concomitant MV procedure to optimally relieve LVOTO. 15 Using multimodality imaging, we sought to quantify MV and PM abnormalities in obstructive HCM patients without severe basal septal hypertrophy. We also sought to determine whether these abnormalities are associated with dynamic LVOTO in such patients; along with implications for corrective surgery.
Methods

Study Sample
The current observational study sample was derived from an institutional review board-approved registry of patients with HCM at a single tertiary care center. The diagnosis of HCM was made by clinicians experienced in diagnosis and management of patients with HCM (including ventricular myocardial hypertrophy occurring in the absence of any other cardiac or systemic disease, family history of HCM with suggestive features in the patient, septal to posterior wall ratio >1.3, evidence of dynamic LVOTO, and SAM of the MV). 3 Our registry database contained a total of 612 patients with a diagnosis of HCM who were assessed by both CMR and echocardiography. Of this group, we identified 121 consecutive patients who satisfied the following criteria: basal septal thickness <1.8 cm measured by echocardiography and confirmed on CMR, (2) no degenerative MV disease or previous MV surgery, (3) no hypertensive heart disease of elderly and concomitant LVOTO, [22] [23] [24] [25] and (4) absence of ≥mild aortic/ mitral stenosis. A cutoff of 1.8 cm for septal thickness was chosen after discussion with cardiothoracic surgery as the lower limit below which we consider septal hypertrophy not likely to be the sole cause of LVOTO. In addition, in such patients, extensive surgical myectomy might increase the likelihood of a ventricular septal defect. Demographic, clinical, and medication data were obtained.
Echocardiography
All patients underwent comprehensive echocardiograms using commercially available instruments (Philips Medical Systems, WA; Siemens Medical Solutions Inc, PA; and General Electric, WI) as part of standard workup. Maximal chamber dimensions, LV ejection fraction, and end-diastolic LV wall thickness were measured in a standard fashion. 26 Resting LVOT peak velocity was measured by continuouswave Doppler echocardiography, and resting LVOT pressure gradient was estimated by using simplified Bernoulli equation. Care was taken to avoid contamination of the LVOT waveform by mitral regurgitation. In patients with resting LVOT gradients <30 mm Hg, maneuvers including Valsalva and amyl nitrite were used to provoke LVOT gradient. In patients with resting gradients <100 mm Hg, we performed exercise echocardiography to assess postexercise LVOT gradient, as it is a more objective assessment of patients' functional capacity. 27 In patients with resting peak LVOT gradient >100 mm Hg, provocative maneuvers were not used. Maximal LVOT gradient was recorded and defined as the highest recorded gradient (either resting or provoked, including exercise) in a patient. 28 Anterior and posterior MV leaflet lengths were measured (from leaflet tip to hinge point at aortomitral curtain) in multiple views (parasternal long axis, 2-chamber, 4-chamber, and 3-chamber), and an average length was calculated ( Figure 1 ; and Movie I in the Data Supplement). The presence (or absence) of an abnormal chordal attachment (attachment to the mid or base of the anterior mitral leaflet) was also recorded ( Figure 2 ; Movie II in the Data Supplement). The degree of resting mitral regurgitation was assessed using multiple different criteria. 29 Diastolic function was assessed, based on multiple standard criteria. 30
Cardiac Magnetic Resonance
The CMR examinations were performed on standard 1.5-Tesla scanners (Philips Medical Systems). Scout images were initially acquired to identify the cardiac axes. For assessment of PM morphology, LV wall thickness (including basal septum), and global cardiac function, balanced steady-state free precession images were acquired in short axis, as well as 2-, 3-, and 4-chamber views: echo time=1.6 ms, repetition time=3.3 ms, flip angle=70°, and slice thickness=6 mm (longaxis images) or 8 to 10 mm (contiguous short-axis images from apex to base). For short-axis images, field of view varied from 228 to 330 in the x-direction and 260 to 330 in the y-direction, and matrix size varied from 140 to 180 in the x-direction and 256 in the y-direction), giving a spatial resolution of 1.5 to 2.1 mm (x-direction) by 1.1 to 1.4 mm (y-direction). In long-axis images, field of view varied from 250 to 320 (x-direction) and 280 to 340 (y-direction). Matrix size varied from 120 to 210 in the x-direction and 256 in the y-direction (phase encoding direction), giving a spatial resolution of 1.5 to 2.1 mm (xdirection) by 1.1 to 1.6 mm (y-direction). For patients able to suspend respiration, breath hold duration was 10 to 15 s, depending on the heart rate; otherwise, images were acquired using 3 signal averages. Maximal anterobasal septal thickness was recorded during end-diastole from short-axis views using standard software tools (Extended Brilliance Workspace, Philips Medical Systems). In each PM group (anterolateral and posteromedial), number of PM heads were recorded ( Figure 4 ), along with their total area (on short-axis cine stack at end-diastole using standard tools). On the basis of a previous report, PMs were further characterized on short axis, 2-, 3-, and 4-chamber cine views, as follows 31 : (type 1) undivided PM, giving rise to all chordae tendinae, which fan out to corresponding hemivalves; (type 2) PM divided along sagittal plane into 2 heads, 1 head supporting the posterior leaflet, the other related to commissural region and to anterior leaflet; (type 3) PM divided in coronal plane into multiple heads, with a single head related exclusively to commissural zone, whereas the remaining heads supported chordae to anterior and posterior leaflets; and (type 4) complex PM, characterized by division along a coronal plane and by staged origin of the different heads. The presence of abnormal chordal attachment to the base of the anterior mitral leaflet was confirmed on CMR ( Figure 2 ; Movie II in the Data Supplement).
Using standard software (TeraRecon Aquarius), we then visually evaluated the 4-and 3-chamber cine images for systolic hypermobility of bifid PMs (Figure 3 ; Movie III in the Data Supplement). Subsequently, on 3-and 4-chamber views, we quantified the degree of bifid PM-head mobility using the following steps ( Figure 5 ): (1) during end-diastole, we drew a straight line across the lateral wall (on 4-chamber view for anterolateral and 3-chamber for posteromedial PM) followed by another straight line touching the leading edge of PM head closest to the interventricular septum, creating a PM/free wall angle, (2) repeating the same steps during end systole, and (3) the difference between the end-diastolic cine and end-systolic angle was recorded as bifid PM mobility. The maximum mobility in a given patient (from either anterolateral or posteromedial PMs) was recorded. Using 3 and 4-chamber view, we also categorized the location of the distal-most portion of the PMs within the LV cavity as follows: first, we measured the distance from the MV to the LV apex and divided the LV cavity into 3 portions: basal one third, mid one third, and apical one third. Subsequently, a ratio of PM-apex distance to MV-apex distance was created, and PM location within the LV was categorized as follows: (1) basal if the ratio was <0.33, (2) mid ventricular, if the ratio was between 0.33 and 0.66, and (3) apical, if the ratio was >0.66. All CMR analysis was blinded to clinical and echocardiographic data.
Surgical Relief of LVOTO
A subset of patients with HCM, who were intractably symptomatic, underwent surgery to relieve LVOTO. Decision to operate, along with the precise type of operation, was made after a detailed review of imaging data. The final decision of the exact type of operation was made by the cardiothoracic surgeon, after review of intraoperative echocardiogram and direct visualization of anatomy. Details of cardiac surgery were recorded. Surgeries were categorized as isolated myectomy, minimyectomy±MV repair/replacement±PM reorientation, isolated MV repair/replacement, or isolated PM reorientation. 15, 32 At the end of the surgery, all patients (except those who had an MV replacement) underwent intraoperative isoproterenol infusion testing for provocable LVOTO.
Control Sample
In addition, we also included a group of 20 normal controls who had undergone echocardiography and CMR for symptom evaluation (palpitations, dyspnea, and chest discomfort) but were subsequently deemed free of any cardiac disease. Along with demographic data, echocardiographic (mitral leaflet length) and CMR data (basal septal thickness, PM morphology, location within the LV cavity, number of PM heads, PM thickness, and their mobility) were measured as described above.
Statistics
Continuous variables are expressed as a mean±SD or median and compared with the use of the Student t test or ANOVA (for normally distributed variables) or Mann-Whitney test (for non-normally distributed variables). The normality of continuous variables was tested using the Kolmogorov-Smirnov test. Kruskal-Wallis test was used to compare ordinal data among groups. Categorical data are expressed as percentage frequency and compared using χ 2 test or Fisher exact test, as appropriate. Spearman correlation coefficient was used to demonstrate the relationship between 2 continuous variables. The reproducibility of continuous variables was assessed using intraclass correlation coefficients. The intraobserver and interobserver reproducibility of anterior mitral leaflet length (on echocardiography) and bifid PM mobility (on CMR) were assessed in 10 randomly selected patients with a 1-month interval in between measurements. Univariable and forward stepwise multivariable linear regression analysis were performed to test the association between dependent and potential predictors. In addition, receiver operating characteristic curve analysis to test the association between the dependent categorical variable and its potential predictors (continuous variables) was performed. Area under the curve was reported. Statistical analysis was performed using SPSS version 11.5 (SPSS Inc, Chicago, IL). A P value of <0.05 was considered significant.
Results
Baseline characteristics are shown in Table 1 . The mean age of the study sample was 49±17 years, with 60% men. In the group, 37 patients had genetic testing, of which 7 (21%) were positive for known mutations associated with HCM. Despite the fact that 55% of the population had a history of hypertension, it was not deemed severe enough to be the primary cause of ventricular hypertrophy. The mean age of the control group was 46±17 years with 65% men (similar to the study sample, respective P values, 0.3 and 0.4).
Echocardiographic and CMR measurements of the 3 groups (HCM patients with LVOTO, HCM patients without LVOTO, and controls) are shown in Table 2 . No patients had a maximal basal septal thickness of >1.8 cm; all patients had maximal an LV thickness of >1.2 cm. Despite that, 87 (72%) patients had a maximal LVOT gradient of >30 mm Hg. Resting and provocable SAMs were seen in 73 (60%) and 87 (72%) patients. Abnormal MV chordal attachments were noted in 54 (45%) patients with an average anterior MV leaflet length of 2.7±0.4 cm. There were significant differences in basal septal thickness and PM parameters between the patients with HCM and controls.
For the anterior mitral leaflet length, the intraclass correlation coefficient for intraobserver (M.D. measured twice) and interobserver (J.R. and M.D.) reproducibility were 0.91 (0.80-0.97) and 0.89 (0.74-0.95), respectively, both P<0.001. Similarly, for mobility, the intraclass correlation coefficient for intraobserver (M.D. measured twice) and interobserver (P.P. and M.D.) reproducibility were 0.85 (0.61-0.97) and 0.80 (0.54-0.95), respectively, both P<0.01. Figure 5 . Schematic demonstration of how numbers of papillary muscle heads were counted on short-axis stack of cine images on cardiac magnetic resonance. In addition, papillary muscle area was also calculated in these views. Subsequently, we tested the association between maximal LVOT gradient and various potential predictors using linear regression analysis. The results are shown in Table 3 . On univariable analysis, age, basal septal thickness, anterior MV leaflet length, presence of an abnormal chordal attachment to the MV, and bifid PM mobility were significantly associated with LVOTO. However, on stepwise multivariable analysis, age did not remain associated with the presence of LVOTO.
Receiver operating characteristic curve analysis was also performed to test the association between maximal LVOT gradient ≥30 mm Hg and continuous variables of anterior MV length and PM mobility, respectively. The area under the curve for anterior MV leaflet length was 0.70 (CI, 0.57-0.80), P=0.002. An anterior MV leaflet length of 2.5 cm had a sensitivity of 80% and a specificity of 63% for predicting a maximal LVOT gradient of ≥30 mm Hg. Similarly, the area under the curve for bifid PM mobility was 0.66 (CI, 0.53-0.82), P=0.01. PM mobility of 10° had a sensitivity of 74% and a specificity of 61% for predicting a maximal LVOT gradient of ≥30 mm Hg.
Within the study population, 45 patients with significant symptoms because of severe obstructive SAM, intractable to maximal medical therapy, underwent surgery to relieve LVOTO, as follows: 21 (47%) had an isolated myectomy, whereas 24 (53%) had a nonmyectomy approach (13 needing MV repair [plication/shortening of A2 scallop], 4 needed mechanical MV replacement, and 7 underwent PM reorientation with or without a minimyectomy). All surgical procedures occurred within 30 days of baseline multimodality imaging evaluation (mean time, 21±6 days). The relevant characteristics of the study population, divided into 3 subgroups (no surgery, myectomy alone, and nonmyectomy surgical approach) are shown in Table 4 . Patients who required a predominantly nonmyectomy approach had a significantly longer anterior mitral leaflet length and greater bifid PM mobility versus other subgroups. Specifically, the patients who underwent PM reorientation had a significantly high mobility of 17±3°. Also, two third patients in the nonmyectomy group (and none in the isolated myectomy group) had a maximal septal thickness of ≤1.5 cm. There were 0 deaths within 30 days postoperatively, and 98% patients have a provocable LVOT gradient of <50 mm Hg.
Discussion
In this study, we sought to understand the mechanisms of dynamic LVOTO in patients with HCM who do not have severe basal septal hypertrophy (maximal basal septal thickness of ≤1.8 cm). We demonstrate that almost 3 quarters of patients had a SAM-related LVOT gradient. That we were able to identify such a large proportion of patients is likely a result of routine use of provocative maneuvers (eg, amyl nitrite inhalation, Valsalva maneuver, and exercise) and multimodality imaging. Provocable gradients in patients with borderline basal septal hypertrophy should not be dismissed as clinically irrelevant, as many such patients have exercise-induced symptoms. In addition, extensive myectomy or alcohol septal ablations, which rely on debulking of the basal septum, would generally not be feasible in such patients.
When compared with controls, patients with HCM have a significantly higher incidence of MV and PM abnormalities that could potentially account for severe LVOTO. Rather than subjective assessment, we quantified all abnormalities on echocardiography and 3-dimensional (3D) CMR, using the strengths of each modality. Hence, for MV chordal attachments and leaflet length, we used echocardiography because of superior temporal resolution enabling better delineation of highly mobile MV leaflets. On the other hand, because of superior spatial resolution and 3D capabilities, we used CMR for characterization of PM morphology, apical displacement, and quantification of systolic mobility.
We also demonstrate that abnormal chordal attachment to the base of the anterior mitral leaflet, length of the anterior MV leaflet, and increased mobility of bifid PMs were associated with dynamic LVOTO, independent of other factors, including basal septal thickness. Furthermore, an anterior MV length of ≥2.5 cm and a bifid PM mobility of ≥10° had good sensitivity and specificity for prediction of elevated LVOT gradient. Indeed, previous reports have demonstrated that MV and PM abnormalities result in dynamic LVOTO. [18] [19] [20] [21] In 1 previous report, it has been demonstrated that MV leaflets in HCM are elongated independently of other disease variables, likely constituting a primary phenotypic expression. 21 In another study using CMR, it was also demonstrated that there were concomitant PM abnormalities, including increased mass and abnormal chordal attachments, in patients with HCM aiding in LVOTO. 19 We have previously demonstrated that abnormal PM morphology was independently associated with LVOTO. 18 However, in that previous report, a detailed assessment of PM morphology and mobility was not analyzed. Also, this study included only the specific subgroup of HCM patients without severe basal septal hypertrophy, where the findings are most relevant. This study is one of the largest to document this in an objective manner using multimodality imaging.
We further evaluated the clinical relevance of MV and PM abnormalities in a subgroup of the intractably symptomatic study patients who underwent surgical relief of LVOTO. We demonstrate that >50% of such patients required a nonmyectomy approach, to optimally relieve LVOTO, thus providing a potential mechanistic association. We further demonstrate that the subgroup that required a nonmyectomy approach had significantly greater anterior mitral leaflet length and bifid PM mobility versus other subgroups. In patients with an elongated anterior mitral leaflet, there is a tendency for the leaflet to buckle toward the septum during systolic contraction, resulting in LVOT obstruction (Figure 1) . Similarly, in patients with bifid hypermobile PMs, the leading edge of the PM moves close to the interventricular septum during systole resulting in SAM of the mitral leaflet (or cordae) and LVOT obstruction (Figure 3 ). In the past, MV replacement has been the only viable option to relieve LVOT obstruction in such patients. However, in the current era, we strive to avoid MV replacement, as most of these patients with HCM are younger, requiring a mechanical valve with the resultant sequelae of long-term anticoagulation. 15 In patients with an elongated anterior mitral leaflet, we now plicate and shorten the A2 scallop of the MV, thus reducing its contact with the basal septum during systole. Depending on the specific MV problem, the technique of MV repair has to be individualized. In patients where the primary abnormality is bifid PM mobility, we have developed a technique of PM reorientation, as previously described. 32 These techniques have enabled us to significantly reduce the number of mechanical MV replacements, as highlighted in the results. Hence, using multimodality imaging and an individualized approach, we delineate the mechanism of LVOT obstruction (ie, MV and PM abnormalities) and perform a preplanned nonmyectomy procedure (mitral repair±PM reorientation±myectomy) based on imaging findings. 15, 32 
Limitations
This was a retrospective observational study at a tertiary care center, with its inherent biases. We can only demonstrate associations, not causality. As multiple mechanisms for LVOT obstruction may exist, it can be difficult to ascertain the incremental use of different nonmyectomy approaches. It does highlight the fact that multimodality imaging is crucial in delineating the mechanism of LVOT obstruction in these patients. Some of the echocardiographic and CMR measurements were not standardized, further adding to the limitation of the study. These nonstandard measurements, however, were undertaken with the expectation to prove feasibility of the concept of bifid PM mobility and abnormal MV morphologies as being important factors (and under-recognized) resulting in LVOT obstruction. Systematic genetic testing was not performed in all patients. Also, the proportion of gene-positive status was lower in the patients who did undergo genetic testing that what is previously reported. 33 Although this could potentially suggest that some of the patients in this study do not reflect true familial HCM, a definitive assertion cannot be made. Because of a relatively small sample size, it is possible that the false-positive rate may be inflated because of multiple testing, multivariable models may be overfitted, and power to detect differences between subgroups was potentially limited. 
Conclusions
In HCM patients without severe basal septal hypertrophy, greater anterior mitral leaflet length, abnormal chordal attachment, and increased bifid PM mobility are independently associated with dynamic LVOT obstruction. In such patients, surgical MV and PM procedures (±myectomy) guided by detailed individualized imaging could potentially help to optimally alleviate symptomatic LVOT obstruction.
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